Clinical significance of soluble CD30/CD30L and CD40/CD40L system imbalance in ovarian serous tumors
10.3760/cma.j.issn.1674-6090.2016.03.012
- VernacularTitle:卵巢浆液性肿瘤中可溶性CD30/CD30L和CD40/CD40L系统失衡的临床意义
- Author:
Hongfen NI
;
Juanfang SONG
;
Yuehong WU
;
Junmei ZHU
;
Aiying CHENG
- Publication Type:Journal Article
- Keywords:
Ovarian tumor;
CD30/CD30L;
CD40/CD40L
- From:
Chinese Journal of Endocrine Surgery
2016;10(3):225-227
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical significance of soluble CD30/CD30L and CD40/CD40L system imbalance in ovarian serous tumors.Methods 40 patients of serous cystadenoma and 30 patients of serous cystadenocarcinoma were selected,and 40 age-and weight-matched healthy women were also recruited as the control group.Peripheral venous blood (3 ml) of the healthy control and patients with ovarian serous tumors before surgery and 7 days after surgery were collected.After separation of serum,ELISA was used to detect levels of sCD30,sCD30L,sCD40 and sCD40L.Results Compared to the control group,levels of sCD30,sCD30L,sCD40 and sCD40L in both serous cystadenoma and serous cystadenocarcinoma groups were significantly in creased (P＜0.05).And in those serous cystadenocarcinoma group,levels of such soluble proteins were much higher than in serous cystadenoma group (P＜0.05).7 days after surgery,levels of such soluble proteins were significantly decreased in both serous cystadenoma and serous cystadenocarcinoma groups (P＜0.05).Conclusion Detection of serum sCD30/sCD30L and sCD40/sCD40L is possible to have a certain guiding significance to early diagnosis of ovarian tumors and the prognosis of patients.
